ISRCTN ISRCTN14436287
DOI https://doi.org/10.1186/ISRCTN14436287
Secondary identifying numbers 16HC004
Submission date
29/11/2016
Registration date
20/12/2016
Last edited
13/03/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Fragility fractures are a type of fracture which occurs as a result of normal activity, such as a fall from standing height or less. Low-trauma vertebral fractures are fragility fractures affecting the small bones that make up the spine (vertebra). It is most commonly caused by osteoporosis, a long-term condition where bones become brittle and break easily. Vertebral fragility fractures can lead to pain, limitation in daily activities, and is associated with further fragility fractures and worse healthcare outcomes. The majority of vertebral fragility fractures are treated in the community, and so those that do need admission to hospital are more likely to have sustained a serious fracture and be in significant pain and disability. This specific group of patients has not been robustly studied and this study aims to describe the characteristics of patients admitted to hospital with a vertebral fragility fracture, their care in hospital and health outcomes associated with it at six months.

Who can participate?
Adults aged 50 years and over who have been admitted to hospital because of a vertebral fragility fracture or suspected vertebral fragility fracture.

What does the study involve?
Participants who have been admitted to hospital because of a vertebral fragility fracture or suspected vertebral fragility fracture are approached by the study team to complete a number of questionnaires. In addition, their medical records are reviewed for background information about their health. Six months later, participants are contacted and repeat the initial questionnaires to look at the long-term outcomes of their fracture.

What are the possible benefits and risks of participating?
There are no direct benefits or risks to those taking part.

Where is the study run from?
Queens Medical Centre, Nottingham (UK)

When is the study starting and how long is it expected to run for?
August 2016 to March 2018

Who is funding the study?
Dunhill Medical Trust (UK)

Who is the main contact?
Dr Terence Ong
terenceong@doctors.org.uk

Contact information

Dr Terence Ong
Scientific

Department for Healthcare of Older People
Queens Medical Centre
Nottingham University Hospitals NHS Trust
Derby Road
Nottingham
NG7 2UH
United Kingdom

ORCiD logoORCID ID 0000-0001-7473-446X
Phone +44 1159 249924 ext 62793/62511
Email terenceong@doctors.org.uk

Study information

Study designSingle centre prospective observational cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet ISRCTN14436287_PIS_22Sep16_V3.docx
Scientific titleNottingham Spinal Health (NoSH) Study: A cohort study of vertebral fragility fractures admitted to hospital
Study acronymNoSH
Study objectivesThe aim of this study is to describe characteristics of adult patients admitted to hospital with vertebral fragility fractures and their associated outcomes. Findings from this study will inform the potential development of a specialist service for vertebral fracture management in hospital.
Ethics approval(s)Ethics approval provided by the East of England - Cambridge Central Research Ethics Committee, 22/07/2016, ref: 16/EE/0249
Health condition(s) or problem(s) studiedVertebral fractures, including those in patients with osteoporosis
InterventionPatients with a diagnosed or suspected diagnosis of an acute vertebral fragility fracture will be invited to participate in the study. Data collection will be conducted on admission, at discharge from hospital and at 6 months follow up post-discharge. Range of data collected are detailed in the accompanying section of this application. Data will be gathered from patient questionnaire and their medical case notes. This observational study will not interfere with the care delivered as part of their hospital admission.
Intervention typeOther
Primary outcome measure1. Pain is measured using an 11 point numeric rating scale at baseline (on admission to hospital), on discharge from hospital and at 6 months
2. Mood is measured using the Geriatric Depression Scale at baseline (on admission to hospital) and at 6 months
3. Cognition is measured using the Montreal Cognitive Assessment at baseline (on admission to hospital) and at 6 months
4. Disability is measured using the Elderly Mobility Scale, Barthel Index, Nottingham Extended Activities of Daily Living and Roland Morris Disability Questionnaire at baseline (on admission to hospital) and at 6 months
Secondary outcome measures1. Hospital inpatient mortality and overall mortality are measured by analysing healthcare records at 6 months
2. Hospital related outcomes measured by analysing hospital paper and electronic healthcare records on patients discharge - length of stay, discharge destination/changes in residency, hospital related complication (hospital acquired infection, pressure sore, venous thromboembolic event, delirium and neurological impairment)
3. Quality of life post-hospitalisation for vertebral fractures is measured using the EQ-5D measured at 6 months
4. Healthcare resource utilisation after hospital discharge is measured through self or proxy reporting at 6 months
Overall study start date10/08/2016
Completion date15/03/2018

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants100
Key inclusion criteria1. Adults aged 50 years and over
2. Admitted to hospital with either a low trauma or atraumatic vertebral fragility fracture or suspected vertebral fragility fracture pending radiology investigation. A low trauma fracture is a fracture sustained after a fall from a standing height or less. A diagnosis of vertebral fracture is made radiologically (i.e. x-ray imaging, computerised tomography (CT), magnetic resonance imaging (MRI) of the spine) or bone (scintigraphy) scan.
3. While in hospital was diagnosed with a vertebral fragility fracture unrelated to their index admission
Key exclusion criteria1. Patients without a vertebral fracture
2. Patients admitted electively to hospital for management of their vertebral fracture
3. Patients transferred from another hospital
4. Vertebral fracture sustained as a result of a high impact injury, e.g. road traffic accident, fall down a flight of stairs, etc.
5. Patients presenting with a concomitant fracture elsewhere
6. Patients admitted to hospital under a major trauma pathway
7. Patients with known or suspected malignancy
8. Patients with known primary bone disorder (e.g Paget’s disease) other than osteoporosis
9. Patients terminally ill or moribund
Date of first enrolment28/09/2016
Date of final enrolment18/08/2017

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Queens Medical Centre
Nottingham University Hospitals NHS Trust
Derby Road
Nottingham
NG7 2UH
United Kingdom

Sponsor information

Nottingham University Hospitals NHS Trust
Hospital/treatment centre

Research and Innovation
Queens Medical Centre
Derby Road
Nottingham
NG7 2UH
England
United Kingdom

Phone +44 1159 249924 ext 70659
Email researchsponsor@nuh.nhs.uk
Website http://nuhrise.org/
ROR logo "ROR" https://ror.org/05y3qh794

Funders

Funder type

Hospital/treatment centre

Dunhill Medical Trust
Private sector organisation / Other non-profit organizations
Alternative name(s)
The Dunhill Medical Trust, DMT
Location
United Kingdom

Results and Publications

Intention to publish date16/03/2019
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned dissemination of findings through participation at relevant conferences, publication in peer-reviewed journals, clinical and research networks, and engagement with our patient and public involvement group.
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from terenceong@doctors.org.uk

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version V3 22/09/2016 12/01/2017 No Yes
Basic results 14/03/2019 26/03/2019 No No
HRA research summary 26/07/2023 No No

Additional files

ISRCTN14436287_PIS_22Sep16_V3.docx
Uploaded 12/01/2017
ISRCTN14436287_BasicResults_14Mar19.pdf
Uploaded 26/03/2019

Editorial Notes

13/03/2020: Internal review.
06/11/2019: Internal review.
26/03/2019: The basic results of this trial have been uploaded as an additional file.
12/01/2017: Uploaded participant information sheet.